Evidence map›Paper›PMID 32184845›Full record

ArticleIranian journal of pharmaceutical research : IJPR2019

Synthesis and

Wilson Castrillón, Angie Herrera-R, Laura Juliana Prieto, Laura Conesa-Milián, Miguel Carda, Tonny Naranjo, Maria Elena Maldonado, Wilson Cardona-G

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wilson CastrillónQuímica de Plantas Colombianas, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia (UdeA), Calle 70 No. 52-21, A.A 1226, Medellín, Colombia.
Angie Herrera-RQuímica de Plantas Colombianas, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia (UdeA), Calle 70 No. 52-21, A.A 1226, Medellín, Colombia.
Laura Juliana PrietoQuímica de Plantas Colombianas, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia (UdeA), Calle 70 No. 52-21, A.A 1226, Medellín, Colombia.
Laura Conesa-MiliánDepartment of Inorganic and Organic Chemistry, University Jaume I, E-12071 Castellón, Spain.
Miguel CardaDepartment of Inorganic and Organic Chemistry, University Jaume I, E-12071 Castellón, Spain.
Tonny NaranjoGrupo de Micología Médica y Experimental, Corporación para Investigaciones Biológicas, Medellín, Colombia.
Maria Elena MaldonadoGrupo Impacto de los Componentes Alimentarios en la Salud, School of Nutrition and Dietetics, University of Antioquia (UdeA), A.A. 1226 Medellín.
Wilson Cardona-GQuímica de Plantas Colombianas, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia (UdeA), Calle 70 No. 52-21, A.A 1226, Medellín, Colombia.
Universidad de Antioquia · COUniversidad Pontificia Bolivariana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have synthesized a series of S-allyl cysteine ester-caffeic acid amide hybrids and evaluated them in order to determine their possible anticancer activity and selectivity in colorectal cancer, which is still one of the leading causes of morbidity and mortality worldwide. All compounds were tested against SW480 human colon adenocarcinoma cells and the non-malignant CHO-K1 cell line. Among the tested compounds, hybrids

Indexed as

Caffeic acidCell deathColorectal cancerHybridS-allyl cysteine

Identifiers

PMID32184845
PMCPMC7059070
OpenAlexW2992083347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.